Guanfacine: Oral tablet, extended release (1mg)
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Par Pharmaceuticals, an Endo Company
Mylan Pharmaceuticals Inc.
Actavis US
Teva Pharmaceuticals USA
AvKARE, Inc.
What is this Medicine?
GUANFACINE (GWAHN fa seen) is used to treat attention-deficit hyperactivity disorder (ADHD).
Guanfacine 1mg Extended-Release Tablet
NDC: 103700533-
Prescription Required
-
Not a Controlled Drug
(CSA Schedule) -
FDA Approved
Attention-deficit Hyperactivity Disorder (ADHD)
Store at controlled room temperature (between 68 and 77 degrees F)
Reported Side Effects for Guanfacine 1mg Extended-Release Tablet
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: RAPID
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: RAPID
Onset: DELAYED
Onset: RAPID
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.



Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Be the first to share your experience!
We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.


